المؤلفون: Meyskens, F L, Jr, Kopecky, K J, Appelbaum, F R, Balcerzak, S P, Samlowski, W, Hynes, H

المصدر: Leukemia research. 19(9)

مصطلحات موضوعية: Antineoplastic Agents, Alkylating: administration & dosage, Blast Crisis, Busulfan: administration & dosage, Female, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive: drug therapy, Male, Middle Aged, Survival Analysis, Vitamin A: administration & dosage, busulfan, Chronic myelogenous leukemia, differentiation, retinoids, vitamin Abusulfan, retinol, abdominal cramp, adult, alopecia, anemia, anorexia, article, bone pain, chronic myeloid leukemia, clinical trial, controlled clinical trial, controlled study, diarrhea, drug hypersensitivity, esophagus ulcer, fatigue, female, gastrointestinal symptom, headache, hot flush, human, hyperpigmentation, leukocyte count, leukopenia, liver dysfunction, major clinical study, male, mucosa inflammation, myalgia, nausea, neurologic disease, oral drug administration, personality disorder, priority journal, prothrombin time, randomized controlled trial, stomach ulcer, thrombocyte count, thrombocytopenia, vertigo, vomiting, weight reduction, xerostomia, Antineoplastic Agents, Alkylating, Blast Crisis, Busulfan, Female, Humans, Leukemia, Myeloid, Chronic, Leukemia, Myeloid, Philadelphia-Positive, Male, Middle Aged, Survival Analysis, Vitamin A

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/44q9g8b2Test

المؤلفون: Vink, P., Torrell, J.M.R., Fructuoso, A.S., Kim, Sung-Joo, Kim, Sang-Il, Zaltzman, J., Ortiz, F., Plana, J.M.C., Rodriguez, A.M.F., Rodrigo, H.R., Marti, M.C., Perez, R., Roncero, F.M.G., Kumar, D., Chiang, Y.-J., Doucette, K., Pipeleers, L., Morales, M.L.A., Rodriguez-Ferrero, M.L., Secchi, Antonio, McNeil, S.A., Campora, L., Di Paolo, E., El Idrissi, M., López-Fauqued, M., Salaun, B., Heineman, T.C., Oostvogels, L.

المساهمون: Clinicum, HUS Abdominal Center

مصطلحات موضوعية: vomiting, Herpesvirus 3, Human, drug safety, myalgia, glycoprotein E, diarrhea, gastrointestinal symptom, Antibodies, Viral, Immunogenicity, Vaccine, recombinant vaccine, humoral immunity, calcineurin inhibitor, Herpes Zoster Vaccine, Herpes zoster vaccine, kidney function, fever, 11832 Microbiology and virology, Vaccines, Synthetic, adult, creatinine, Burkitt lymphoma, immunosuppressive treatment, clinical trial, nausea, Immunogenicity, Renal transplant, female, priority journal, kidney graft, Varicella zoster virus, injection site erythema, mucosa inflammation, Safety, CD4 antigen, bacterial meningitis, injection site pain, mycophenolic acid, Adult, corticosteroid, side effect, kidney transplantation, herpes zoster, cellular immunity, antibody titer, Herpes Zoster, Article, virus antibody, injection site swelling, shivering, vaccine immunogenicity, varicella zoster vaccine, male, Humans, controlled study, drug fatality, human, single blind procedure, CD4+ T lymphocyte, phase 3 clinical trial, rapamycin, abdominal pain, immune deficiency, vaccination, graft recipient, major clinical study, Kidney Transplantation, febrile neutropenia, multicenter study, randomized controlled trial, placebo, fatigue, kidney graft rejection, Immunosuppression

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1593::e4343157674e2db802bf9ea13d92f415Test
http://hdl.handle.net/10138/327850Test

المؤلفون: Osman Manavoglu, Ekrem Kaya, Lütfi Özkan, Meral Kurt, Sevilcan Aygun, Turkkan Evrensel, Tulay Palazoglu, Ozkan Kanat, Ender Kurt, Sibel Kahraman Çetintaş

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Cerrahisi Anabilim Dalı., Kurt, Ender, Kurt, Meral, Kanat, Özkan, Çetintaş, Sibel Kahraman, Aygun, Sevilcan, Palazoğlu, Julay, Özkan, Lütfi, Evrensel, Türkkan, Kaya, Ekrem, Manavoğlu, Osman, AAJ-1027-2021, AAG-7319-2021, AAA-7047-2020, AAA-3961-2020

المصدر: Tumori Journal. 92:481-486

مصطلحات موضوعية: Male, Oncology, Cancer Research, Survival, medicine.medical_treatment, Phases of clinical research, Kaplan-Meier Estimate, Treatment response, Deoxycytidine, Gastroenterology, Trial, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Controlled clinical trial, Antineoplastic Combined Chemotherapy Protocols, Disease course, Pancreas cancer, Remission Induction, Anemia, Nausea, Chemoradiotherapy, General Medicine, Middle Aged, Clinical trial, Treatment Outcome, Chemoradiation, Tolerability, Chemotherapy, Adjuvant, Fluorouracil, Cancer radiotherapy, 030220 oncology & carcinogenesis, Induction chemotherapy, Combination, Drug dose reduction, Female, Human, medicine.drug, Adult, Diarrhea, medicine.medical_specialty, Neutropenia, Duodenum ulcer, Clinical article, External beam radiotherapy, 130-Nm Albumin-Bound Paclitaxel, Gemcitabine, Pancreatic Neoplasms, Disease-Free Survival, Article, 03 medical and health sciences, Mucosa inflammation, Advanced cancer, Internal medicine, Gfluorouracil, medicine, Humans, Phase 2 clinical trial, Neoplasm Staging, Aged, Chemotherapy, Radiotherapy, business.industry, Carcinoma, Resection, medicine.disease, Thrombocytopenia, Cancer survival, Cancer combination chemotherapy, Cooperative-oncology-group, Radiation-therapy, Radiotherapy, Adjuvant, Dose Fractionation, Radiation, Pancreatic carcinoma, Bolus injection, business, Controlled study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6491eed56d4066e3a4d228bf69488020Test
https://doi.org/10.1177/030089160609200603Test

المؤلفون: Pentheroudakis, George, Pavlidis, Nicholas

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Pentheroudakis, George [0000-0002-6632-2462]

المصدر: Expert opinion on pharmacotherapy

مصطلحات موضوعية: Drug dose regimen, Oncology, Hydrocortisone, Carcinogenesis, Life expectancy, medicine.medical_treatment, Dermatitis, Review, Antipyretic agent, Diagnostic accuracy, Dna topoisomerases, Breast cancer, Leukoencephalopathy, Antineoplastic agents, Meningeal Neoplasms, Pharmacology (medical), Enzyme Inhibitors, Cerebrospinal fluid analysis, Injections, Spinal, Adenocarcinoma/pathology, Enzyme Inhibitors/therapeutic use, Palliative Care, Headache, General Medicine, Prognosis, Antineoplastic, Alkylating, Management, Arachnoid Cysts, Clinical trial, Nuclear magnetic resonance imaging, Spinal cord disease, Randomized controlled trials, Reverse transcription polymerase chain reaction, fluid/therapeutic use, Topotecan/therapeutic use, Rituximab, Lymphoma/pathology, Human, Antimetabolites, Antineoplastic, medicine.medical_specialty, Leptomeninx, Bone marrow suppression, Vomiting, Leptomeningeal, Adenocarcinoma, Irinotecan, Beta 2 microglobulin, Disease association, Drug formulation, Meningism, Humans, Combined Modality Therapy, Molecular mechanics, Antineoplastic Agents, Alkylating, High risk population, Steroid, Pharmacology, Carcinoma/*drug therapy/radiotherapy/secondary, Type i, medicine.disease, Lymphoma, Radiation therapy, Myelin basic protein, Methotrexate, Arachnoiditis, Delayed-Action Preparations, Laboratory diagnosis, Risk factor, Topoisomerase I Inhibitors, Palliative care, Antimetabolites, Meningeal Neoplasms/*drug therapy/radiotherapy/secondary, Dexamethasone, Cancer risk, Arachnoid cysts, Photophobia, Thiotepa/administration & dosage/cerebrospinal fluid/therapeutic use, Nephrotoxicity, Randomized Controlled Trials as Topic, Meningeal metastasis, Leukemia, Cytarabine, Folinic acid, Lactate dehydrogenase, Nausea, Combined modality therapy, Enzyme inhibitors, Antineoplastic Agents, Alkylating/administration & dosage/cerebrospinal, Sensitivity and specificity, Cranial irradiation, Injections, Intravenous, Cytarabine/administration & dosage/cerebrospinal fluid/therapeutic use, Meningeal neoplasms, Mafosfamide, Intravenous, Carcinomatous meningitis, Algorithms, Drug elimination, Fever, Spinal, Liver toxicity, Drug response, Cerebellum disease, Arachnoid Cysts/*drug therapy/etiology/radiotherapy, Drug half life, Neuroimaging, Malignancy, Injections, Methotrexate/administration & dosage/cerebrospinal fluid/therapeutic use, Aseptic meningitis, Mucosa inflammation, Internal medicine, Computer assisted tomography, Temozolomide, medicine, Leukemia/pathology, Antimetabolites, Antineoplastic/administration & dosage/cerebrospinal, Vasculotropin, Performance status, business.industry, Carcinoma, Trastuzumab, Cancer survival, Surgery, Drug efficacy, Carcinoembryonic antigen, Delayed-action preparations, Cranial Irradiation, Antiemetic agent, Topotecan, Cytology, business, Thiotepa

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833bf06fd03c56e21514d92c7baec460Test
https://doi.org/10.1517/14656566.6.7.1115Test

المؤلفون: Murat Arslan, Ender Kurt, Guzin Gonullu, Mutlu Demiray, Ozkan Kanat, Osman Manavoglu, Turkkan Evrensel

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Bilim Dalı., Kanat, Özkan, Evrensel, Türkkan, Kurt, Ender, Demiray, Mutlu, Gönüllü, Güzin, Arslan, Murat, Manavoğlu, Osman, AAJ-1027-2021, M-8060-2019

المصدر: Tumori Journal. 90:192-195

مصطلحات موضوعية: Male, Oncology, Cancer Research, Phases of clinical research, Single Center, Deoxycytidine, Gastroenterology, Trial, Metastasis, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Bolus (medicine), Antineoplastic Combined Chemotherapy Protocols, 5-fluorouracil, Pancreas cancer, Survival time, Drug tolerability, Analgesics, Leukopenia, Anemia, Pancreas Adenocarcinoma, Gemcitabine, Pancreatic Neoplasms, General Medicine, Middle Aged, Serotonin 3 antagonist, Clinical trial, Treatment Outcome, Fluorouracil, 030220 oncology & carcinogenesis, Injections, Intravenous, Disease Progression, Female, medicine.symptom, Human, medicine.drug, Adult, Diarrhea, Antimetabolites, Antineoplastic, medicine.medical_specialty, Clinical article, Drug response, Adenocarcinoma, Drug Administration Schedule, Article, Drug toxicity, 03 medical and health sciences, Mucosa inflammation, Internal medicine, medicine, Mucositis, Humans, Chemotherapy, High-dose leucovorin, Phase 2 clinical trial, Aged, business.industry, Body Weight, Pancreatic cancer, medicine.disease, Survival Analysis, Thrombocytopenia, Cancer survival, Cancer combination chemotherapy, Drug effect, Drug efficacy, Regimen, Tract cancer, Antiemetic agent, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb1e7af86667f6cfc6f7a594cb91f8e8Test
https://doi.org/10.1177/030089160409000206Test

المؤلفون: Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Fountzilas, George, Christodoulou, C., Papadimitriou, C., Pavlidis, Nicholas, Kalofonos, H. P., Gogas, H., Kosmidis, Paraskevas A., Dimopoulos, M. A.

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]

المصدر: Annals of Oncology

مصطلحات موضوعية: medicine.medical_treatment, Docetaxel, Skin disease, Gastroenterology, Carboplatin, Granulocyte colony-stimulating factor, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Prospective Studies, Treatment outcome, Drug safety, Etoposide, Ovarian Neoplasms, Multicenter study, Clinical trial, Oxaliplatin, Local, Oncology, Vertigo, Disease Progression, Taxoids, Infection, Human, Diarrhea, Neoplasm recurrence, medicine.medical_specialty, Bone marrow suppression, Paclitaxel, Clinical article, Febrile neutropenia, Antineoplastic Agents, Methylprednisolone, Article, Disease-Free Survival, Ovarian cancer, Humans, Platinum-resistant, Cancer recurrence, Aged, Disease progression, Drug infusion, Recombinant granulocyte colony stimulating factor, Follow up, Myalgia, Leukopenia, Monotherapy, medicine.disease, Cancer combination chemotherapy, Drug effect, Regimen, Drug resistance, Cisplatin, Ovarian neoplasms, Controlled clinical trial, Nausea and vomiting, Phytogenic, Middle aged, Fatigue, Priority journal, Platinum derivative, Anemia, Vinorelbine, Hematology, Middle Aged, Arthralgia, Ondansetron, Anorexia, Treatment Outcome, Drug choice, Female, medicine.symptom, medicine.drug, Adult, Abdominal pain, Neutropenia, Ovary cancer, Disease-free survival, Navelbine, Vinblastine, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Phase 2 clinical trial, Stomatitis, business.industry, Alopecia, Taxane derivative, Gemcitabine, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Cancer survival, Surgery, Drug efficacy, Doxorubicin, Drug Resistance, Neoplasm, Neoplasm, Neoplasm Recurrence, Local, Antiemetic agent, Topotecan, business, Controlled study, Constipation, Prospective studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e836ea784e7dd1d62801cbb6bcc90bTest
https://doi.org/10.1093/annonc/mdg292Test

المؤلفون: Francesco Ricciuti, Maria Concetta Petti, Felicetto Ferrara, Eugenio Gallo, Eros Di Bona, Rosangela Invernizzi, Francesco Lo-Coco, M. L. Vegna, Sergio Amadori, Mario Lazzarino, Giuseppe Avvisati, Guglielmo Mariani, Simona Sica, Franco Mandelli, Nicola Cantore, Carmine Selleri, Giuseppe Fioritoni, Dino Veneri, Vincenzo Liso, Michele Baccarani

المصدر: Blood. 100:3141-3146

مصطلحات موضوعية: Male, leukocyte count, vomiting, medicine.medical_treatment, diarrhea, heart failure, idarubicin, Biochemistry, Gastroenterology, Hepatitis, law.invention, Leukemia, Promyelocytic, Acute, Randomized controlled trial, cytarabine, Antibiotics, law, cancer diagnosis, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Medicine, promyelocytic leukemia, cancer survival, Child, Promyelocytic, Antibiotics, Antineoplastic, Leukemia, adult, Remission Induction, article, Age Factors, clinical trial, Hematology, Middle Aged, Antineoplastic, Chemotherapy regimen, female, multivariate analysis, Treatment Outcome, priority journal, cancer regression, monotherapy, drug induced disease, mucosa inflammation, Chemical and Drug Induced Liver Injury, Infection, mercaptopurine, methotrexate, tioguanine, bleeding, cancer combination chemotherapy, controlled clinical trial, controlled study, drug infusion, follow up, human, infection, kidney failure, liver failure, major clinical study, male, multicenter study, randomized controlled trial, survival time, 6-Mercaptopurine, Adolescent, Adult, Cytarabine, Disease-Free Survival, Female, Follow-Up Studies, Hemorrhage, Hepatitis, Toxic, Humans, Idarubicin, Leukocyte Count, Methotrexate, Vomiting, medicine.drug, Acute promyelocytic leukemia, medicine.medical_specialty, Anthracycline, Immunology, Acute, Infections, Internal medicine, Chemotherapy, business.industry, Cell Biology, Toxic, medicine.disease, Surgery, business, Settore MED/15 - Malattie del Sangue

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60a37d5f4ba5607eb18ed1ef5654059Test
https://doi.org/10.1182/blood-2002-02-0352Test

المؤلفون: Fountzilas, George, Dafni, U., Papadimitriou, C., Timotheadou, E., Gogas, H., Eleftheraki, A. G., Xanthakis, I., Christodoulou, C., Koutras, A. K., Papandreou, C. N., Papakostas, P., Miliaras, S., Markopoulos, C., Dimitrakakis, C., Korantzopoulos, Panagiotis, Karanikiotis, C., Bafaloukos, Dimitrios, Kosmidis, Paraskevas A., Samantas, E., Varthalitis, I., Pavlidis, Nicholas, Pectasides, Dimitrios, Dimopoulos, M. A.

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]

المصدر: BMC Cancer

مصطلحات موضوعية: Oncology, Survival rate, Neurologic disease, Docetaxel, Skin disease, Multiple cycle treatment, Eye disease, Breast cancer, Phase 3 clinical trial, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Pathology, Drug fatality, Anthracyclines, Disease free survival, Open study, Fulvestrant, Mastectomy, Dose-dense sequential chemotherapy, Multicenter study, Clinical trial, Antineoplastic agent, Randomized controlled trial, Granulocyte colony stimulating factor, Goserelin, Thrombocyte, Infection, Human, Diarrhea, medicine.medical_specialty, Paclitaxel, Vomiting, Febrile neutropenia, Heart failure, Antineoplastic Agents, Major clinical study, Side effect, Heart disease, Anastrozole, Vascular disease, Article, Disease-Free Survival, Drug Administration Schedule, Epidermal growth factor receptor 2, Taxanes, Median follow-up, Genetics, Humans, Hemoglobin, Phase 3 clinical trial (topic), Cyclophosphamide, Aged, Follow up, Leukopenia, Myalgia, medicine.disease, Metabolic disorder, Cancer combination chemotherapy, Regimen, Tamoxifen, Methotrexate, Cancer adjuvant therapy, Asymptomatic disease, Comparative study, Breast neoplasms, Cancer Research, Partial mastectomy, Heart ejection fraction, Gonadorelin, Skin manifestation, Monoclonal, Edema, Overall survival, Middle aged, Humanized, Fatigue, Adjuvant, Drug withdrawal, Neutrophil, Nausea, Middle Aged, Gastrointestinal disease, Arthralgia, Anorexia, Chemotherapy, Adjuvant, Cancer radiotherapy, Female, Fluorouracil, Epirubicin, medicine.drug, Research Article, Monoclonal antibody, Adult, Neutropenia, Disease-free survival, Pain, Breast Neoplasms, Follow-up studies, Antibodies, Monoclonal, Humanized, Antibodies, Young Adult, Mucosa inflammation, Internal medicine, Antineoplastic combined chemotherapy protocols, medicine, Chemotherapy, Early cancer, Taxane, business.industry, Drug administration, Loading drug dose, Lymphocytopenia, Drug administration schedule, Allergic reaction, Patient compliance, Aromatase inhibitor, Leukocyte, Trastuzumab, Adjuvant chemotherapy, Drug efficacy, Young adult, Lung disease, business, Controlled study, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f05a4fb1c5cce316e6477713a4950eTest
https://pubmed.ncbi.nlm.nih.gov/25026897Test

المؤلفون: Economopoulos, T., Psyrri, A., Dimopoulos, M. A., Kalogera-Fountzila, Anna, Pavlidis, Nicholas, Tsatalas, C., Nikolaides, C., Mellou, S., Xiros, N., Fountzilas, George

المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Kalogera-Fountzila, Anna 0000-0002-6801-3129

المصدر: Cancer Journal

مصطلحات موضوعية: Article, Antineoplastic agent, Cyclophosphamide, Human, Prednisone, Vincristine, 80 and over, Aged, Humans, Adult, Controlled study, Female, Major clinical study, Cancer combination chemotherapy, Cancer growth, Priority journal, Alopecia, Anemia, Anorexia, Antineoplastic combined chemotherapy protocols, Clinical trial, Controlled clinical trial, Diarrhea, Fatigue, Febrile neutropenia, Infection, Leukopenia, Mucosa inflammation, Multicenter study, Nausea and vomiting

العلاقة: https://gnosis.library.ucy.ac.cy/handle/7/41604Test

الإتاحة: https://doi.org/10.1097/PPO.0b013e3181570170Test
https://gnosis.library.ucy.ac.cy/handle/7/41604Test

المؤلفون: Fountzilas, George, Ch, F. Tolis, Kalogera-Fountzila, Anna, Misailidou, D., Tsekeris, P., Karina, M., Nikolaou, A., Samantas, E., Makatsoris, T., Athanassiou, E., Skarlos, Dimosthenis V., Bamias, A. T., Zamboglou, N., Economopoulos, T., Karanastassi, S., Pavlidis, Nicholas, Daniilidis, J.

المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Kalogera-Fountzila, Anna 0000-0002-6801-3129

المصدر: Medical Oncology

مصطلحات موضوعية: Article, Cisplatin, Fluorouracil, Human, Humans, Adult, Aged, Controlled study, Female, Middle aged, Cancer growth, Cancer survival, Chemotherapy, Follow up, Priority journal, Alopecia, Anemia, Anorexia, Antineoplastic combined chemotherapy protocols, Clinical article, Clinical trial, Constipation, Controlled clinical trial, Fatigue, Febrile neutropenia, Infection, Leukopenia, Mucosa inflammation, Myalgia, Nausea and vomiting

العلاقة: https://gnosis.library.ucy.ac.cy/handle/7/41679Test

الإتاحة: https://doi.org/10.1385/MO:22:3:269Test
https://gnosis.library.ucy.ac.cy/handle/7/41679Test